-+ 0.00%
-+ 0.00%
-+ 0.00%

Lixte Biotechnology Holdings Inc. Outlines Strategy to Advance LB-100 Combination Therapy, Strengthen Financial Foundation, and Support Multi-Year Clinical Development

Reuters·12/03/2025 13:00:45

Please log in to view news